The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Gesine Paul-Visse receives 3 million SEK from Cancerfonden

project group

Gesine Paul-Visse and consultant neurologist and clinical fellow Robert Carlsson received 3 million SEK of funding by Cancerfonden covering 3 years for their project.

The already ongoing project entitled “Modulating key targets in pericytes: impact on tumor infiltration and immune evasion in glioblastoma” will investigate if and how modulation of previously selected targets in pericytes antagonize infiltrative growth and immune evasion of gliomas. 

This project will provide novelty on key targets and their functional implications in the pathological context of glioblastoma that have the potential to limit tumor progression. Most of the work will be carried out in Gesine’s lab by PhD student Carolina Buizza and Gayatri Chitale as part of the of their PhD and master thesis.